Botanical Drug Industry Research Report 2023
Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
Highlights
The global Botanical Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.
The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.
Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
The Botanical Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Botanical Drug type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Botanical Drug are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Botanical Drug segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Botanical Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Botanical Drug market.
Botanical Drug Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Botanical Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Botanical Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Botanical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Botanical Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.
The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.
Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
The Botanical Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Buchang Pharmaceuticals
- China TCM
- Tsumura
- Schwabe
- Tong Ren Tang
- Jumpcan Pharmaceutical
- Guangzhou Baiyunshan Pharmaceutical
- Yunnan Baiyao
- Tasly Holding Group
- Bionorica Se
- Huarun 999
- Taiji
- Weleda
- Kwangdong
- GW Pharmaceuticals
Global markets are presented by Botanical Drug type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Botanical Drug are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Botanical Drug segment by Type
- Prescription Drug
- OTC
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Botanical Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Botanical Drug market.
Botanical Drug Segment by Application
- Cardiovascular
- Tumor
- Respiratory System
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Botanical Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Botanical Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Botanical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Botanical Drug Revenue Market Share by Type (2018-2023)
Table 7. Global Botanical Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Botanical Drug Revenue Market Share by Type (2024-2029)
Table 9. Global Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Botanical Drug Revenue Market Share by Application (2018-2023)
Table 11. Global Botanical Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Botanical Drug Revenue Market Share by Application (2024-2029)
Table 13. Global Botanical Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Botanical Drug Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Botanical Drug Market Share by Region (2018-2023)
Table 16. Global Botanical Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Botanical Drug Market Share by Region (2024-2029)
Table 18. Botanical Drug Market Trends
Table 19. Botanical Drug Market Drivers
Table 20. Botanical Drug Market Challenges
Table 21. Botanical Drug Market Restraints
Table 22. Global Top Botanical Drug Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Botanical Drug Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Botanical Drug Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Botanical Drug, Headquarters and Area Served
Table 26. Global Botanical Drug Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Botanical Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Buchang Pharmaceuticals Company Detail
Table 46. Buchang Pharmaceuticals Business Overview
Table 47. Buchang Pharmaceuticals Botanical Drug Product
Table 48. Buchang Pharmaceuticals Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 49. Buchang Pharmaceuticals Recent Development
Table 50. China TCM Company Detail
Table 51. China TCM Business Overview
Table 52. China TCM Botanical Drug Product
Table 53. China TCM Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 54. China TCM Recent Development
Table 55. Tsumura Company Detail
Table 56. Tsumura Business Overview
Table 57. Tsumura Botanical Drug Product
Table 58. Tsumura Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 59. Tsumura Recent Development
Table 60. Schwabe Company Detail
Table 61. Schwabe Business Overview
Table 62. Schwabe Botanical Drug Product
Table 63. Schwabe Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 64. Schwabe Recent Development
Table 65. Tong Ren Tang Company Detail
Table 66. Tong Ren Tang Business Overview
Table 67. Tong Ren Tang Botanical Drug Product
Table 68. Tong Ren Tang Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 69. Tong Ren Tang Recent Development
Table 70. Jumpcan Pharmaceutical Company Detail
Table 71. Jumpcan Pharmaceutical Business Overview
Table 72. Jumpcan Pharmaceutical Botanical Drug Product
Table 73. Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 74. Jumpcan Pharmaceutical Recent Development
Table 75. Guangzhou Baiyunshan Pharmaceutical Company Detail
Table 76. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 77. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
Table 78. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 79. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 80. Yunnan Baiyao Company Detail
Table 81. Yunnan Baiyao Business Overview
Table 82. Yunnan Baiyao Botanical Drug Product
Table 83. Yunnan Baiyao Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 84. Yunnan Baiyao Recent Development
Table 85. Tasly Holding Group Company Detail
Table 86. Tasly Holding Group Business Overview
Table 87. Tasly Holding Group Botanical Drug Product
Table 88. Tasly Holding Group Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 89. Tasly Holding Group Recent Development
Table 90. Bionorica Se Company Detail
Table 91. Bionorica Se Business Overview
Table 92. Bionorica Se Botanical Drug Product
Table 93. Bionorica Se Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 94. Bionorica Se Recent Development
Table 95. Huarun 999 Company Detail
Table 96. Huarun 999 Business Overview
Table 97. Huarun 999 Botanical DrugProduct
Table 98. Huarun 999 Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 99. Huarun 999 Recent Development
Table 100. Taiji Company Detail
Table 101. Taiji Business Overview
Table 102. Taiji Botanical DrugProduct
Table 103. Taiji Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 104. Taiji Recent Development
Table 105. Weleda Company Detail
Table 106. Weleda Business Overview
Table 107. Weleda Botanical DrugProduct
Table 108. Weleda Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 109. Weleda Recent Development
Table 110. Kwangdong Company Detail
Table 111. Kwangdong Business Overview
Table 112. Kwangdong Botanical DrugProduct
Table 113. Kwangdong Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 114. Kwangdong Recent Development
Table 115. GW Pharmaceuticals Company Detail
Table 116. GW Pharmaceuticals Business Overview
Table 117. GW Pharmaceuticals Botanical DrugProduct
Table 118. GW Pharmaceuticals Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 119. GW Pharmaceuticals Recent Development
Table 120. Buchang Pharmaceuticals Company Information
Table 121. Buchang Pharmaceuticals Business Overview
Table 122. Buchang Pharmaceuticals Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 123. Buchang Pharmaceuticals Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 124. Buchang Pharmaceuticals Recent Development
Table 125. China TCM Company Information
Table 126. China TCM Business Overview
Table 127. China TCM Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 128. China TCM Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 129. China TCM Recent Development
Table 130. Tsumura Company Information
Table 131. Tsumura Business Overview
Table 132. Tsumura Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 133. Tsumura Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 134. Tsumura Recent Development
Table 135. Schwabe Company Information
Table 136. Schwabe Business Overview
Table 137. Schwabe Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 138. Schwabe Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 139. Schwabe Recent Development
Table 140. Tong Ren Tang Company Information
Table 141. Tong Ren Tang Business Overview
Table 142. Tong Ren Tang Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 143. Tong Ren Tang Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 144. Tong Ren Tang Recent Development
Table 145. Jumpcan Pharmaceutical Company Information
Table 146. Jumpcan Pharmaceutical Business Overview
Table 147. Jumpcan Pharmaceutical Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 148. Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 149. Jumpcan Pharmaceutical Recent Development
Table 150. Guangzhou Baiyunshan Pharmaceutical Company Information
Table 151. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 152. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 153. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 154. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 155. Yunnan Baiyao Company Information
Table 156. Yunnan Baiyao Business Overview
Table 157. Yunnan Baiyao Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 158. Yunnan Baiyao Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 159. Yunnan Baiyao Recent Development
Table 160. Tasly Holding Group Company Information
Table 161. Tasly Holding Group Business Overview
Table 162. Tasly Holding Group Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 163. Tasly Holding Group Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 164. Tasly Holding Group Recent Development
Table 165. Bionorica Se Company Information
Table 166. Bionorica Se Business Overview
Table 167. Bionorica Se Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 168. Bionorica Se Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 169. Bionorica Se Recent Development
Table 170. Huarun 999 Company Information
Table 171. Huarun 999 Business Overview
Table 172. Huarun 999 Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 173. Huarun 999 Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 174. Huarun 999 Recent Development
Table 175. Taiji Company Information
Table 176. Taiji Business Overview
Table 177. Taiji Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 178. Taiji Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 179. Taiji Recent Development
Table 180. Weleda Company Information
Table 181. Weleda Business Overview
Table 182. Weleda Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 183. Weleda Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 184. Weleda Recent Development
Table 185. Kwangdong Company Information
Table 186. Kwangdong Business Overview
Table 187. Kwangdong Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 188. Kwangdong Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 189. Kwangdong Recent Development
Table 190. GW Pharmaceuticals Company Information
Table 191. GW Pharmaceuticals Business Overview
Table 192. GW Pharmaceuticals Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 193. GW Pharmaceuticals Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 194. GW Pharmaceuticals Recent Development
Table 195. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Botanical Drug Revenue Market Share by Type (2018-2023)
Table 7. Global Botanical Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Botanical Drug Revenue Market Share by Type (2024-2029)
Table 9. Global Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Botanical Drug Revenue Market Share by Application (2018-2023)
Table 11. Global Botanical Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Botanical Drug Revenue Market Share by Application (2024-2029)
Table 13. Global Botanical Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Botanical Drug Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Botanical Drug Market Share by Region (2018-2023)
Table 16. Global Botanical Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Botanical Drug Market Share by Region (2024-2029)
Table 18. Botanical Drug Market Trends
Table 19. Botanical Drug Market Drivers
Table 20. Botanical Drug Market Challenges
Table 21. Botanical Drug Market Restraints
Table 22. Global Top Botanical Drug Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Botanical Drug Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Botanical Drug Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Botanical Drug, Headquarters and Area Served
Table 26. Global Botanical Drug Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Botanical Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Buchang Pharmaceuticals Company Detail
Table 46. Buchang Pharmaceuticals Business Overview
Table 47. Buchang Pharmaceuticals Botanical Drug Product
Table 48. Buchang Pharmaceuticals Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 49. Buchang Pharmaceuticals Recent Development
Table 50. China TCM Company Detail
Table 51. China TCM Business Overview
Table 52. China TCM Botanical Drug Product
Table 53. China TCM Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 54. China TCM Recent Development
Table 55. Tsumura Company Detail
Table 56. Tsumura Business Overview
Table 57. Tsumura Botanical Drug Product
Table 58. Tsumura Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 59. Tsumura Recent Development
Table 60. Schwabe Company Detail
Table 61. Schwabe Business Overview
Table 62. Schwabe Botanical Drug Product
Table 63. Schwabe Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 64. Schwabe Recent Development
Table 65. Tong Ren Tang Company Detail
Table 66. Tong Ren Tang Business Overview
Table 67. Tong Ren Tang Botanical Drug Product
Table 68. Tong Ren Tang Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 69. Tong Ren Tang Recent Development
Table 70. Jumpcan Pharmaceutical Company Detail
Table 71. Jumpcan Pharmaceutical Business Overview
Table 72. Jumpcan Pharmaceutical Botanical Drug Product
Table 73. Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 74. Jumpcan Pharmaceutical Recent Development
Table 75. Guangzhou Baiyunshan Pharmaceutical Company Detail
Table 76. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 77. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
Table 78. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 79. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 80. Yunnan Baiyao Company Detail
Table 81. Yunnan Baiyao Business Overview
Table 82. Yunnan Baiyao Botanical Drug Product
Table 83. Yunnan Baiyao Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 84. Yunnan Baiyao Recent Development
Table 85. Tasly Holding Group Company Detail
Table 86. Tasly Holding Group Business Overview
Table 87. Tasly Holding Group Botanical Drug Product
Table 88. Tasly Holding Group Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 89. Tasly Holding Group Recent Development
Table 90. Bionorica Se Company Detail
Table 91. Bionorica Se Business Overview
Table 92. Bionorica Se Botanical Drug Product
Table 93. Bionorica Se Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 94. Bionorica Se Recent Development
Table 95. Huarun 999 Company Detail
Table 96. Huarun 999 Business Overview
Table 97. Huarun 999 Botanical DrugProduct
Table 98. Huarun 999 Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 99. Huarun 999 Recent Development
Table 100. Taiji Company Detail
Table 101. Taiji Business Overview
Table 102. Taiji Botanical DrugProduct
Table 103. Taiji Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 104. Taiji Recent Development
Table 105. Weleda Company Detail
Table 106. Weleda Business Overview
Table 107. Weleda Botanical DrugProduct
Table 108. Weleda Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 109. Weleda Recent Development
Table 110. Kwangdong Company Detail
Table 111. Kwangdong Business Overview
Table 112. Kwangdong Botanical DrugProduct
Table 113. Kwangdong Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 114. Kwangdong Recent Development
Table 115. GW Pharmaceuticals Company Detail
Table 116. GW Pharmaceuticals Business Overview
Table 117. GW Pharmaceuticals Botanical DrugProduct
Table 118. GW Pharmaceuticals Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 119. GW Pharmaceuticals Recent Development
Table 120. Buchang Pharmaceuticals Company Information
Table 121. Buchang Pharmaceuticals Business Overview
Table 122. Buchang Pharmaceuticals Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 123. Buchang Pharmaceuticals Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 124. Buchang Pharmaceuticals Recent Development
Table 125. China TCM Company Information
Table 126. China TCM Business Overview
Table 127. China TCM Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 128. China TCM Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 129. China TCM Recent Development
Table 130. Tsumura Company Information
Table 131. Tsumura Business Overview
Table 132. Tsumura Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 133. Tsumura Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 134. Tsumura Recent Development
Table 135. Schwabe Company Information
Table 136. Schwabe Business Overview
Table 137. Schwabe Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 138. Schwabe Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 139. Schwabe Recent Development
Table 140. Tong Ren Tang Company Information
Table 141. Tong Ren Tang Business Overview
Table 142. Tong Ren Tang Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 143. Tong Ren Tang Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 144. Tong Ren Tang Recent Development
Table 145. Jumpcan Pharmaceutical Company Information
Table 146. Jumpcan Pharmaceutical Business Overview
Table 147. Jumpcan Pharmaceutical Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 148. Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 149. Jumpcan Pharmaceutical Recent Development
Table 150. Guangzhou Baiyunshan Pharmaceutical Company Information
Table 151. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 152. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 153. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 154. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 155. Yunnan Baiyao Company Information
Table 156. Yunnan Baiyao Business Overview
Table 157. Yunnan Baiyao Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 158. Yunnan Baiyao Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 159. Yunnan Baiyao Recent Development
Table 160. Tasly Holding Group Company Information
Table 161. Tasly Holding Group Business Overview
Table 162. Tasly Holding Group Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 163. Tasly Holding Group Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 164. Tasly Holding Group Recent Development
Table 165. Bionorica Se Company Information
Table 166. Bionorica Se Business Overview
Table 167. Bionorica Se Botanical Drug Revenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 168. Bionorica Se Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 169. Bionorica Se Recent Development
Table 170. Huarun 999 Company Information
Table 171. Huarun 999 Business Overview
Table 172. Huarun 999 Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 173. Huarun 999 Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 174. Huarun 999 Recent Development
Table 175. Taiji Company Information
Table 176. Taiji Business Overview
Table 177. Taiji Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 178. Taiji Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 179. Taiji Recent Development
Table 180. Weleda Company Information
Table 181. Weleda Business Overview
Table 182. Weleda Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 183. Weleda Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 184. Weleda Recent Development
Table 185. Kwangdong Company Information
Table 186. Kwangdong Business Overview
Table 187. Kwangdong Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 188. Kwangdong Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 189. Kwangdong Recent Development
Table 190. GW Pharmaceuticals Company Information
Table 191. GW Pharmaceuticals Business Overview
Table 192. GW Pharmaceuticals Botanical DrugRevenue in Botanical Drug Business (2018-2023) & (US$ Million)
Table 193. GW Pharmaceuticals Revenue in Botanical Drug Business (2018-2023) & (US$ Million) Portfolio
Table 194. GW Pharmaceuticals Recent Development
Table 195. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Botanical Drug Product Picture
Figure 5. Global Botanical Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Botanical Drug Market Share by Type: 2022 VS 2029
Figure 7. Prescription Drug Product Picture
Figure 8. OTC Product Picture
Figure 9. Global Botanical Drug Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Botanical Drug Market Share by Application: 2022 VS 2029
Figure 11. Cardiovascular Product Picture
Figure 12. Tumor Product Picture
Figure 13. Respiratory System Product Picture
Figure 14. Others Product Picture
Figure 15. Global Botanical Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Botanical Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Botanical Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Botanical Drug Market Share by Players in 2022
Figure 19. Global Botanical Drug Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Botanical Drug Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Botanical Drug Market Share by Country (2018-2029)
Figure 24. United States Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Botanical Drug Market Share by Country (2018-2029)
Figure 28. Germany Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Botanical Drug Market Share by Country (2018-2029)
Figure 36. China Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Botanical Drug Market Share by Country (2018-2029)
Figure 44. Mexico Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Botanical Drug Market Share by Country (2018-2029)
Figure 48. Turkey Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Buchang Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 52. China TCM Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 53. Tsumura Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 54. Schwabe Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 55. Tong Ren Tang Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 56. Jumpcan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 57. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 58. Yunnan Baiyao Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 59. Tasly Holding Group Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 60. Bionorica Se Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 61. Huarun 999 Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 62. Taiji Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 63. Weleda Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 64. Kwangdong Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 65. GW Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Botanical Drug Product Picture
Figure 5. Global Botanical Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Botanical Drug Market Share by Type: 2022 VS 2029
Figure 7. Prescription Drug Product Picture
Figure 8. OTC Product Picture
Figure 9. Global Botanical Drug Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Botanical Drug Market Share by Application: 2022 VS 2029
Figure 11. Cardiovascular Product Picture
Figure 12. Tumor Product Picture
Figure 13. Respiratory System Product Picture
Figure 14. Others Product Picture
Figure 15. Global Botanical Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Botanical Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Botanical Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Botanical Drug Market Share by Players in 2022
Figure 19. Global Botanical Drug Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Botanical Drug Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Botanical Drug Market Share by Country (2018-2029)
Figure 24. United States Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Botanical Drug Market Share by Country (2018-2029)
Figure 28. Germany Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Botanical Drug Market Share by Country (2018-2029)
Figure 36. China Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Botanical Drug Market Share by Country (2018-2029)
Figure 44. Mexico Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Botanical Drug Market Share by Country (2018-2029)
Figure 48. Turkey Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Buchang Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 52. China TCM Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 53. Tsumura Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 54. Schwabe Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 55. Tong Ren Tang Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 56. Jumpcan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 57. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 58. Yunnan Baiyao Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 59. Tasly Holding Group Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 60. Bionorica Se Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 61. Huarun 999 Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 62. Taiji Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 63. Weleda Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 64. Kwangdong Revenue Growth Rate in Botanical Drug Business (2018-2023)
Figure 65. GW Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2018-2023)
